US20140336691A1 - Methods and systems for performing thrombectomy procedures - Google Patents
Methods and systems for performing thrombectomy procedures Download PDFInfo
- Publication number
- US20140336691A1 US20140336691A1 US14/336,898 US201414336898A US2014336691A1 US 20140336691 A1 US20140336691 A1 US 20140336691A1 US 201414336898 A US201414336898 A US 201414336898A US 2014336691 A1 US2014336691 A1 US 2014336691A1
- Authority
- US
- United States
- Prior art keywords
- balloon member
- catheter
- distal end
- balloon
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
- A61B17/22032—Gripping instruments, e.g. forceps, for removing or smashing calculi having inflatable gripping elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
Definitions
- the field of intralumenal therapy for the treatment of vascular disease states has for many years focused on the use of many different types of therapeutic devices. While it is currently unforeseeable that one particular device will be suitable to treat all types of vascular disease states, it may however be possible to reduce the number of devices used for some disease states while at the same time improve patient outcomes at a reduced cost. To identify potential opportunities to improve the efficiency and efficacy of the devices and procedures it is important for one to understand the state of the art relative to some of the more common disease states.
- one aspect of cerebrovascular disease in which the wall of a blood vessel becomes weakened. Under cerebral flow conditions the weakened vessel wall forms a bulge or aneurysm which can lead to symptomatic neurological deficits or ultimately a hemorrhagic stroke when ruptured.
- embolization devices include detachable balloons, coils, polymerizing liquids, gels, foams, stents and combinations thereof.
- embolization devices are detachable embolization coils. These coils are generally made from biologically inert platinum alloys. To treat an aneurysm, the coils are navigated to the treatment site under fluoroscopic visualization and carefully positioned within the dome of an aneurysm using sophisticated, expensive delivery systems. Typical procedures require the positioning and deployment of multiple embolization coils which are then packed to a sufficient density as to provide a mechanical impediment to flow impingement on the fragile diseased vessel wall. Some of these bare embolization coil systems have been describe in U.S. Pat. No.
- stent like scaffolds have been developed to provide support for coils. These types of stent like scaffolds for use in the treatment of aneurysms have been described in U.S. Pat. No. 6,605,111 to Bose et al., entitled, “Endovascular Thin Film Devices and Methods for Treating Strokes” and U.S. Pat. No. 6,673,106 to Mitelberg, et al., entitled, “Intravascular Stent Device”.
- Another cerebrovascular disease state is ischemia resulting from reduced or blocked arterial blood flow.
- the arterial blockage may be due to thrombus, plaque, foreign objects or a combination thereof.
- soft thrombus created elsewhere in the body for example due to atrial fibrillation
- thrombolytic drugs While guidewires are typically used to disrupt the thrombus, some sophisticated thrombectomy devices have been proposed. For instance U.S. Pat. No. 4,762,130 to Fogarty et al., entitled, “Catheter with Corkscrew-Like Balloon”, U.S. Pat. No.
- Atherosclerotic disease Plaque buildup within the lumen of the vessel, known as atherosclerotic disease, is not generally responsive to thrombolytics or mechanical disruption using guidewires.
- the approach to the treatment of neurovascular atherosclerotic disease has been to use modified technology developed for the treatment of cardiovascular atherosclerotic disease, such as balloons and stents, to expand the vessel at the site of the lesion to re-establish blood flow.
- modified technology developed for the treatment of cardiovascular atherosclerotic disease such as balloons and stents
- the coil spring stent is deployed when an outer cylinder is moved proximally allowing the stent to expand.
- Other stent systems include those disclosed in U.S. Pat. No. 4,512,338 to Balko, et al., entitled, “Process for Restoring Patency to Body Vessels”, U.S. Pat. No. 5,354,309 to Schnepp Pesch et al., entitled, “Apparatus for Widening a Body Cavity” and U.S. Pat. No. 6,833,003 to Jones et al., entitled, “Expandable Stent and Delivery System”. While the aforementioned devices may have the ability to access the cerebrovasculature, they lack sufficient structural coverage of the lesion to achieve the desired patency of the vessel without the use of a balloon device.
- the thrombectomy system includes a thrombectomy catheter having proximal and distal ends including a proximal hub, a balloon member having proximal and distal ends, including a longitudinally extending portion and a radially expanding retrieval portion, where the balloon member proximal end is coupled to the catheter distal end and an inflation source member coupled to the proximal hub.
- the extending portion of the balloon member has an inflated diameter which is smaller than the inflated diameter of the retrieval portion.
- An elongate tether member is positioned within the catheter lumen and preferably coupled to the balloon member distal end. The tether member extends proximally through the thrombectomy catheter lumen and proximal to the proximal end of the hub assembly.
- the balloon member For delivery to a desired target site, the balloon member is everted and positioned within the lumen of the thrombectomy catheter such that the distal end of the balloon member is proximal to the distal end of the catheter.
- the balloon member of the delivery catheter is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed and the proximal end of the balloon member is coupled to the distal end of the catheter such that the lumen of the catheter is in fluid communication with the interior surface of the balloon.
- the balloon member is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable.
- the inflation source member is coupled to the proximal end of the catheter and used to apply fluid pressure to the lumen of catheter at a level sufficient to cause the balloon member extending portion to extend longitudinally from the catheter lumen and subsequently deploy and expand the capture portion of the balloon member.
- the preferred fluids include liquids such as saline although gases such as carbon dioxide gas may be suitable for some system configurations.
- the amount of fluid pressure required to inflate the balloon member is related to the friction force between the balloon member inner surface and the interior wall of the catheter lumen.
- the inflation source member preferably takes the form of a syringe (threaded or non-threaded), however other inflation sources such as a pressurized fluid source having a valve assembly or a controllable fluid delivery pump are also suitable.
- a balloon member for a thrombectomy system having a longitudinally extending portion formed of a non-compliant material and a radially expanding retrieval portion formed of a compliant material.
- compliant materials include polymeric elastomers such as silicones, urethanes, polyether block amide (PEBAX) and synthetic rubbers including polyisoprene, nitrile, chloroprene and ethylene propylene diene rubber.
- a balloon member for a thrombectomy system having a longitudinally extending portion and a radially expanding retrieval portion coupled to a thrombectomy catheter where the inflated diameter of the extending portion is larger than the outer diameter of the thrombectomy catheter.
- a balloon member for a thrombectomy system having a longitudinally extending portion and a radially expanding retrieval portion coupled to a thrombectomy catheter where the inflated diameter of the extending portion is smaller than the outer diameter of the thrombectomy catheter.
- FIG. 1 is a partial cross-sectional view of a thrombectomy system according to an embodiment of the present invention.
- FIG. 2A is an enlarged partial cross-sectional view of the distal end of the thrombectomy system according to an embodiment of the present invention.
- FIG. 2B is an enlarged partial cross-sectional view of the distal end of a thrombectomy system according to another embodiment of the present invention.
- FIG. 3A is a partial cross sectional view of a deployed thrombectomy system according to an embodiment of the present invention.
- FIG. 3B is a partial cross sectional view of a deployed thrombectomy system according to another embodiment of the present invention.
- FIG. 3C is a partial cross sectional view of a deployed thrombectomy system according to yet another embodiment of the present invention.
- FIGS. 4A through 4F partial cross-sectional views illustrating a method of delivering and deploying a thrombectomy system within a vessel at a target site according to an embodiment of the present invention.
- FIG. 1 illustrates a thrombectomy system 10 according to an embodiment of the present invention.
- Thrombectomy system 10 includes an elongate catheter 20 having distal end 22 , proximal end 24 including hub member 26 and lumen 28 extending therethrough. Coupled to distal end 22 of catheter 20 is balloon member 30 .
- An elongate flexible tether member 32 coupled to balloon member 30 is slidably positioned within lumen 28 and extends through hub member 26 .
- Balloon member 30 has a delivery configuration in which it is everted and positioned within lumen 28 of catheter 20 at distal end 22 .
- Proximal end 24 of catheter 20 is coupled to hub member 26 which includes sealable valve 34 and inflation port 36 .
- FIG. 2A A partial cross sectional view of distal end 22 of catheter 20 is shown in FIG. 2A .
- the construction of catheter 20 may utilize known catheter technologies that incorporate braiding and or coiling using metallic or non-metallic reinforcing filamentous materials to provide high strength while maintaining catheter flexibility.
- the incorporation of lubricious hydrophilic and or hydrophobic materials on the inner and or outer surface of the catheter is considered to be within the scope of known catheter construction techniques and suitable for use in a thrombectomy system according to embodiments of the present invention.
- Retaining member 38 is used to affix proximal end 40 of balloon member 30 to catheter distal end 22 .
- balloon member proximal end 40 is slightly larger than the outer diameter of catheter distal end 22 thereby allowing distal end 22 to be inserted within proximal end 40 .
- Retaining member 38 is shown as a flexible filament (preferably polymeric) wound around proximal end 40 and catheter distal end 22 securing balloon member 30 to catheter 20 .
- Balloon member proximal end 40 and distal end 22 may be secured using other means such as heat fusing, multifilament winds, ultrasonic welding and or gluing to insure a good bond and seal.
- the distal end 42 of balloon member 30 is completely sealed using any of the aforementioned techniques and positioned everted within catheter lumen 28 proximal to balloon member proximal end 40 .
- Balloon member 30 includes a proximally located longitudinally extending portion 44 and a distally located radially expanding retrieval portion 50 .
- FIG. 2B illustrates an alternate embodiment of the present invention showing thrombectomy system 110 .
- Thrombectomy system 110 includes an elongate catheter 120 having delivery portion 122 and guidewire portion 124 .
- Guidewire portion 124 having through lumen 126 extends proximally to the proximal end of catheter 120 .
- guidewire portion 124 and lumen 126 may extend proximally only a portion of the length of catheter 120 and have a configuration suitable for use as a “rapid exchange” system allowing system 110 to reach a target site over a guidewire that has already been positioned at the target site.
- Delivery portion 122 includes lumen 128 extending from the proximal end to the distal end of catheter 120 .
- An elongate flexible tether member 132 is coupled to balloon member 130 and extends proximally through catheter lumen 128 .
- Securing member 138 shown as a wound filament, affixes balloon member proximal end 140 to the distal end of delivery portion 122 .
- Balloon member proximal end 140 and the distal end of delivery portion 122 may be secured using other means such as heat fusing, ultrasonic welding, multifilament winds and or gluing to insure a good bond and seal.
- the distal end 142 of balloon member 130 is completed sealed using any of the aforementioned techniques and positioned everted within catheter lumen 128 proximal to proximal end 140 .
- FIG. 3A shows an enlarged partial cross sectional view of the distal portion of thrombectomy system 10 including catheter 20 having distal end 22 .
- Balloon member 30 is shown in an inflated configuration longitudinally extending distal to catheter distal end 22 .
- balloon member distal end 42 is positioned distal to balloon member proximal end 40 .
- Extending portion 44 of balloon member 30 has a diameter slightly smaller than catheter 20 and ranges from about 0.4 to about 0.99 times the diameter of catheter 20 and has a preferred range from about 0.5 to 0.9 times the diameter of catheter 20 .
- Balloon member 30 is typically formed of a thin walled polymeric tube having a proximal non-compliant portion defining extending portion 44 coupled to a distal compliant portion defining retrieval portion 50 that has been sealed.
- the tube portions may be joined using known joining techniques such as, thermal fusing, ultrasonic welding, gluing, and solvent bonding.
- Suitable materials for the extending portion of balloon member 30 include high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable.
- Suitable materials for the retrieval portion 50 of balloon member 30 includes compliant polymeric elastomers such as silicones, urethanes, polyether block amide (PEBAX) and synthetic rubbers including polyisoprene, nitrile, chloroprene and ethylene propylene diene rubber.
- compliant polymeric elastomers such as silicones, urethanes, polyether block amide (PEBAX) and synthetic rubbers including polyisoprene, nitrile, chloroprene and ethylene propylene diene rubber.
- FIGS. 3B and 3C are partial cross sectional views of thrombectomy systems according to alternate embodiments of the present invention that illustrate different configurations of inflated extended balloon members.
- FIG. 3B shows an enlarged partial cross sectional view of the distal portion of thrombectomy system 210 including catheter 220 having distal end 222 .
- Balloon member 230 is shown in an inflated configuration longitudinally extending distal to catheter distal end 222 . In this configuration, balloon member distal end 242 is positioned distal to balloon member proximal end 240 .
- Extending portion 244 of balloon member 230 has a diameter slightly smaller than catheter 220 and ranges from about 0.4 to about 0.99 times the diameter of catheter 220 and has a preferred range from about 0.5 to 0.9 times the diameter of catheter 220 .
- the expanded diameter of retrieval portion 250 is slightly larger than the inner diameter of the vessel at a target site to insure that the retrieval portion stays in contact with the vessel wall during the thrombus removal process.
- Balloon member 230 is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed. Balloon member 230 is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable.
- FIG. 3C shows an enlarged partial cross sectional view of the distal portion of thrombectomy system 310 .
- Balloon member 330 is shown in an inflated configuration longitudinally extending distal to catheter distal end 322 .
- balloon member distal end 342 and retrieval portion are positioned distal to balloon member proximal end 340 and extending portion 344 .
- Extending portion 344 of balloon member 330 has a diameter slightly larger than catheter 320 and ranges from about 1.0 to about 1.5 times the diameter of catheter 320 and has a preferred range from about 1.05 to 1.3 times the diameter of catheter 320 .
- the expanded diameter of retrieval portion 350 is slightly larger than the inner diameter of the vessel at a target site to insure that the retrieval portion stays in contact with the vessel wall during the thrombus removal process.
- Balloon member 330 is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed.
- Balloon member 330 is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable.
- FIGS. 4A through 4F illustrate a method of deploying a retrieval assembly at a target site within a body lumen according to one embodiment of the present invention.
- the thrombectomy system 10 is positioned within a vessel 400 .
- Catheter distal end 22 including extendable balloon member 30 are positioned at a target site adjacent to thrombus 410 .
- An inflation source member (not shown) is coupled to the proximal end of the catheter 20 and used to apply fluid pressure to the lumen of catheter.
- the inflation source member preferably takes the form of a syringe (threaded or non-threaded), however other inflation sources such as a pressurized fluid source having a valve assembly or a controllable fluid delivery pump are also suitable.
- the preferred fluids include liquids such as saline and radiopaque contrasts solutions however gases such as carbon dioxide gas may be suitable for some system configurations.
- gases such as carbon dioxide gas may be suitable for some system configurations.
- balloon member 30 begins to extend longitudinally from the catheter lumen.
- leading edge 415 of the balloon member 30 may encounter thrombus 410 .
- thrombus 410 While shown as large particle, thrombus 410 may have a varied composition that could comprise organized clot, tissue, plaque soft clot or even foreign objects. Dependant somewhat upon the size and composition of thrombus 410 balloon member 30 may extend longitudinally through a soft and compliant thrombus or between the inner vessel wall and a more rigid thrombus.
- Leading edge 415 of balloon member 30 is well suited to extend longitudinally between the more rigid thrombus and the vessel wall without perforating the vessel. With continued application of fluid pressure, balloon member 30 continues to extend longitudinally until retrieval 50 is deployed and positioned distal to thrombus 410 . Once retrieval portion 50 is appropriately deployed, application of additional fluid pressure is unnecessary. As shown in FIG. 4E , thrombectomy system 10 including tether member 32 is pulled proximally causing retrieval portion 50 to engage the distal side of thrombus 410 . Tether member 32 ensures that sufficient retraction force is applied directly to retrieval portion 50 to move thrombus 410 . Thrombectomy system 10 with thrombus 410 may then be removed from the body.
- thrombectomy system 10 with captured thrombus 410 may be pulled proximally within larger catheter 420 having distal end 422 and lumen 424 . Suction may then be applied to lumen 424 thus aiding retention of thrombus 410 during removal or to fragment and remove thrombus 410 .
Abstract
Devices, systems and methods are provided for performing intra-lumenal medical procedures in a desired area of the body. Thrombectomy systems and methods of performing medical procedures to re-establish the intravascular flow of blood are provided for the treatment of ischemic disease states.
Description
- This application claims the benefit of U.S. Prov. Ser. 61/525,362 filed Aug. 19, 2011 which is hereby incorporated by reference herein in its entirety.
- The field of intralumenal therapy for the treatment of vascular disease states has for many years focused on the use of many different types of therapeutic devices. While it is currently unforeseeable that one particular device will be suitable to treat all types of vascular disease states, it may however be possible to reduce the number of devices used for some disease states while at the same time improve patient outcomes at a reduced cost. To identify potential opportunities to improve the efficiency and efficacy of the devices and procedures it is important for one to understand the state of the art relative to some of the more common disease states.
- For instance, one aspect of cerebrovascular disease in which the wall of a blood vessel becomes weakened. Under cerebral flow conditions the weakened vessel wall forms a bulge or aneurysm which can lead to symptomatic neurological deficits or ultimately a hemorrhagic stroke when ruptured. Once diagnosed a small number of these aneurysms are treatable from an endovascular approach using various embolization devices. These embolization devices include detachable balloons, coils, polymerizing liquids, gels, foams, stents and combinations thereof.
- The most widely used embolization devices are detachable embolization coils. These coils are generally made from biologically inert platinum alloys. To treat an aneurysm, the coils are navigated to the treatment site under fluoroscopic visualization and carefully positioned within the dome of an aneurysm using sophisticated, expensive delivery systems. Typical procedures require the positioning and deployment of multiple embolization coils which are then packed to a sufficient density as to provide a mechanical impediment to flow impingement on the fragile diseased vessel wall. Some of these bare embolization coil systems have been describe in U.S. Pat. No. 5,108,407 to Geremia, et al., entitled, “Method And Apparatus For Placement Of An Embolic Coil” and U.S. Pat. No. 5,122,136 to Guglielmi, et al., entitled, “Endovascular Electrolytically Detachable Guidewire Tip For The Electroformation Of Thrombus In Arteries, Veins, Aneurysms, Vascular Malformations And Arteriovenous Fistulas.” These patents disclose devices for delivering embolic coils at predetermined positions within vessels of the human body in order to treat aneurysms, or alternatively, to occlude the blood vessel at a particular location. Many of these systems, depending on the particular location and geometry of the aneurysm, have been used to treat aneurysms with various levels of success. One drawback associated with the use of bare embolization coils relates to the inability to adequately pack or fill the aneurysm due to the geometry of the coils which can lead to long term recanalization of the aneurysm with increased risk of rupture.
- Some improvements to bare embolization coils have included the incorporation of expandable foams, bioactive materials and hydrogel technology as described in the following U.S. Pat. No. 6,723,108 to Jones, et al., entitled, “Foam Matrix Embolization Device”, U.S. Pat. No. 6,423,085 to Murayama, et al., entitled, “Biodegradable Polymer Coils for Intraluminal Implants” and U.S. Pat. No. 6,238,403 to Greene, et al., entitled, “Filamentous Embolic Device with Expansible Elements.” While some of these improved embolization coils have been moderately successful in preventing or reducing the rupture and re-rupture rate of some aneurysms, the devices have their own drawbacks. For instance, in the case of bioactive coils, the materials eliciting the biological healing response are somewhat difficult to integrate with the coil structure or have mechanical properties incompatible with those of the coil making the devices difficult to accurately position within the aneurysm. In the case of some expandable foam and hydrogel technology, the expansion of the foam or hydrogel is accomplished due to an interaction of the foam or hydrogel with the surrounding blood environment. This expansion may be immediate or time delayed but is generally, at some point, out of the control of the physician. With a time delayed response the physician may find that coils which were initially placed accurately and detached become dislodged during the expansion process leading to subsequent complications.
- For many aneurysms, such as wide necked or fusiform aneurysms the geometry is not suitable for coiling alone. To somewhat expand the use of embolization coils in treating some wide necked aneurysms, stent like scaffolds have been developed to provide support for coils. These types of stent like scaffolds for use in the treatment of aneurysms have been described in U.S. Pat. No. 6,605,111 to Bose et al., entitled, “Endovascular Thin Film Devices and Methods for Treating Strokes” and U.S. Pat. No. 6,673,106 to Mitelberg, et al., entitled, “Intravascular Stent Device”. While these stent like devices have broadened the types of aneurysms amenable to embolization therapy, utilization of these devices in conjunction with embolization devices is technically more complex for the physician, may involve more risk to the patient and have a substantial cost increase for the healthcare system.
- To further expand the types of aneurysm suitable for interventional radiological treatment, improved stent like devices have been disclosed in U.S. Pat. No. 5,824,053 to Khosravi et al., entitled, “Helical Mesh Endoprosthesis and Method”, U.S. Pat. No. 5,951,599 to McCrory, entitled, “Occlusion System for the Endovascular Treatment of and Aneurysm” and U.S. Pat. No. 6,063,111 to Hieshima et al., entitled, “Stent Aneurysm Treatment System and Method.” When placed across the neck of an aneurysm the proposed stent like devices purport to have a sufficient density through the wall of the device to reduce flow in the aneurysm allowing the aneurysm to clot, while at the same time having a low enough density through the wall to allow small perforator vessels adjacent to the aneurysm to remain patent. Stent devices of this nature while having the potential to reduce treatment costs have not been realized commercially due to the difficulty in manufacturing, reliability in delivering the devices to the treatment site and an inability to properly position the denser portion of the stent device accurately over the neck of the aneurysm.
- Another cerebrovascular disease state is ischemia resulting from reduced or blocked arterial blood flow. The arterial blockage may be due to thrombus, plaque, foreign objects or a combination thereof. Generally, soft thrombus created elsewhere in the body (for example due to atrial fibrillation) that lodges in the distal cerebrovasculature may be disrupted or dissolved using mechanical devices and or thrombolytic drugs. While guidewires are typically used to disrupt the thrombus, some sophisticated thrombectomy devices have been proposed. For instance U.S. Pat. No. 4,762,130 to Fogarty et al., entitled, “Catheter with Corkscrew-Like Balloon”, U.S. Pat. No. 4,998,919 of Schepp-Pesh et al., entitled, “Thrombectomy Apparatus”, U.S. Pat. No. 5,417,703 to Brown et al., entitled “Thrombectomy Devices and Methods of Using Same”, and U.S. Pat. No. 6,663,650 to Sepetka et al., entitiled, “Systems, Methods and Devices for Removing Obstructions from a Blood Vessel” discloses devices such as catheter based corkscrew balloons, baskets or filter wires and helical coiled retrievers. Commercial and prototype versions of these devices have shown only marginal improvements over guidewires due to an inability to adequately grasp the thrombus or to gain vascular access distal to the thrombus (i.e. distal advancement of the device pushes the thrombus distally).
- Plaque buildup within the lumen of the vessel, known as atherosclerotic disease, is not generally responsive to thrombolytics or mechanical disruption using guidewires. The approach to the treatment of neurovascular atherosclerotic disease has been to use modified technology developed for the treatment of cardiovascular atherosclerotic disease, such as balloons and stents, to expand the vessel at the site of the lesion to re-establish blood flow. For instance, U.S. Pat. No. 4,768,507 to Fischell et al., entitled, “Intravascular Stent and Percutaneous Insertion Catheter System for the Dilation of an Arterial Stenosis and the Prevention of Arterial Restenosis” discloses a system used for placing a coil spring stent into a vessel for the purposes of enhancing luminal dilation, preventing arterial restenosis and preventing vessel blockage resulting from intimal dissection following balloon and other methods of angioplasty. The coil spring stent is placed into spiral grooves on an insertion catheter. A back groove of the insertion catheter contains the most proximal coil of the coil spring stent which is prevented from springing radially outward by a flange. The coil spring stent is deployed when an outer cylinder is moved proximally allowing the stent to expand. Other stent systems include those disclosed in U.S. Pat. No. 4,512,338 to Balko, et al., entitled, “Process for Restoring Patency to Body Vessels”, U.S. Pat. No. 5,354,309 to Schnepp Pesch et al., entitled, “Apparatus for Widening a Body Cavity” and U.S. Pat. No. 6,833,003 to Jones et al., entitled, “Expandable Stent and Delivery System”. While the aforementioned devices may have the ability to access the cerebrovasculature, they lack sufficient structural coverage of the lesion to achieve the desired patency of the vessel without the use of a balloon device.
- In accordance with one aspect of the present invention there is provided a medical device system for restoring patency of a body lumen in a mammal. The thrombectomy system includes a thrombectomy catheter having proximal and distal ends including a proximal hub, a balloon member having proximal and distal ends, including a longitudinally extending portion and a radially expanding retrieval portion, where the balloon member proximal end is coupled to the catheter distal end and an inflation source member coupled to the proximal hub. The extending portion of the balloon member has an inflated diameter which is smaller than the inflated diameter of the retrieval portion. An elongate tether member is positioned within the catheter lumen and preferably coupled to the balloon member distal end. The tether member extends proximally through the thrombectomy catheter lumen and proximal to the proximal end of the hub assembly.
- For delivery to a desired target site, the balloon member is everted and positioned within the lumen of the thrombectomy catheter such that the distal end of the balloon member is proximal to the distal end of the catheter. The balloon member of the delivery catheter is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed and the proximal end of the balloon member is coupled to the distal end of the catheter such that the lumen of the catheter is in fluid communication with the interior surface of the balloon. The balloon member is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable. The inflation source member is coupled to the proximal end of the catheter and used to apply fluid pressure to the lumen of catheter at a level sufficient to cause the balloon member extending portion to extend longitudinally from the catheter lumen and subsequently deploy and expand the capture portion of the balloon member. The preferred fluids include liquids such as saline although gases such as carbon dioxide gas may be suitable for some system configurations. The amount of fluid pressure required to inflate the balloon member is related to the friction force between the balloon member inner surface and the interior wall of the catheter lumen. The inflation source member preferably takes the form of a syringe (threaded or non-threaded), however other inflation sources such as a pressurized fluid source having a valve assembly or a controllable fluid delivery pump are also suitable.
- In accordance with another aspect of the present invention there is provided a balloon member for a thrombectomy system having a longitudinally extending portion formed of a non-compliant material and a radially expanding retrieval portion formed of a compliant material. Suitable compliant materials include polymeric elastomers such as silicones, urethanes, polyether block amide (PEBAX) and synthetic rubbers including polyisoprene, nitrile, chloroprene and ethylene propylene diene rubber.
- In accordance with another aspect of the present invention there is provided a balloon member for a thrombectomy system having a longitudinally extending portion and a radially expanding retrieval portion coupled to a thrombectomy catheter where the inflated diameter of the extending portion is larger than the outer diameter of the thrombectomy catheter.
- In accordance with another aspect of the present invention there is provided a balloon member for a thrombectomy system having a longitudinally extending portion and a radially expanding retrieval portion coupled to a thrombectomy catheter where the inflated diameter of the extending portion is smaller than the outer diameter of the thrombectomy catheter.
-
FIG. 1 is a partial cross-sectional view of a thrombectomy system according to an embodiment of the present invention. -
FIG. 2A is an enlarged partial cross-sectional view of the distal end of the thrombectomy system according to an embodiment of the present invention. -
FIG. 2B is an enlarged partial cross-sectional view of the distal end of a thrombectomy system according to another embodiment of the present invention. -
FIG. 3A is a partial cross sectional view of a deployed thrombectomy system according to an embodiment of the present invention. -
FIG. 3B is a partial cross sectional view of a deployed thrombectomy system according to another embodiment of the present invention. -
FIG. 3C is a partial cross sectional view of a deployed thrombectomy system according to yet another embodiment of the present invention. -
FIGS. 4A through 4F partial cross-sectional views illustrating a method of delivering and deploying a thrombectomy system within a vessel at a target site according to an embodiment of the present invention. - Methods and systems for capturing and removing an embolus or thrombus from an area of the body are herein described. While the terms “thrombectomy” and “thrombus” generally refer to removal of a specific type of embolus, the usage herein should be considered more broadly to include the removal additional types of emboli such as plaque, solid tissue fragments, clots and foreign objects that may block or restrict the normal flow of blood within the vasculature.
FIG. 1 illustrates athrombectomy system 10 according to an embodiment of the present invention.Thrombectomy system 10 includes anelongate catheter 20 havingdistal end 22,proximal end 24 includinghub member 26 andlumen 28 extending therethrough. Coupled todistal end 22 ofcatheter 20 isballoon member 30. An elongateflexible tether member 32 coupled toballoon member 30 is slidably positioned withinlumen 28 and extends throughhub member 26.Balloon member 30 has a delivery configuration in which it is everted and positioned withinlumen 28 ofcatheter 20 atdistal end 22.Proximal end 24 ofcatheter 20 is coupled tohub member 26 which includessealable valve 34 andinflation port 36. - A partial cross sectional view of
distal end 22 ofcatheter 20 is shown inFIG. 2A . While not shown, the construction ofcatheter 20 may utilize known catheter technologies that incorporate braiding and or coiling using metallic or non-metallic reinforcing filamentous materials to provide high strength while maintaining catheter flexibility. The incorporation of lubricious hydrophilic and or hydrophobic materials on the inner and or outer surface of the catheter is considered to be within the scope of known catheter construction techniques and suitable for use in a thrombectomy system according to embodiments of the present invention. Retainingmember 38 is used to affixproximal end 40 ofballoon member 30 to catheterdistal end 22. The inner diameter of balloon memberproximal end 40 is slightly larger than the outer diameter of catheterdistal end 22 thereby allowingdistal end 22 to be inserted withinproximal end 40. Retainingmember 38 is shown as a flexible filament (preferably polymeric) wound aroundproximal end 40 and catheterdistal end 22 securingballoon member 30 tocatheter 20. Balloon memberproximal end 40 anddistal end 22 may be secured using other means such as heat fusing, multifilament winds, ultrasonic welding and or gluing to insure a good bond and seal. Thedistal end 42 ofballoon member 30 is completely sealed using any of the aforementioned techniques and positioned everted withincatheter lumen 28 proximal to balloon memberproximal end 40.Balloon member 30 includes a proximally located longitudinally extendingportion 44 and a distally located radially expandingretrieval portion 50. -
FIG. 2B illustrates an alternate embodiment of the present invention showingthrombectomy system 110.Thrombectomy system 110 includes anelongate catheter 120 havingdelivery portion 122 andguidewire portion 124.Guidewire portion 124 having throughlumen 126 extends proximally to the proximal end ofcatheter 120. Alternativelyguidewire portion 124 andlumen 126 may extend proximally only a portion of the length ofcatheter 120 and have a configuration suitable for use as a “rapid exchange”system allowing system 110 to reach a target site over a guidewire that has already been positioned at the target site.Delivery portion 122 includeslumen 128 extending from the proximal end to the distal end ofcatheter 120. An elongateflexible tether member 132 is coupled toballoon member 130 and extends proximally throughcatheter lumen 128. Securingmember 138, shown as a wound filament, affixes balloon memberproximal end 140 to the distal end ofdelivery portion 122. Balloon memberproximal end 140 and the distal end ofdelivery portion 122 may be secured using other means such as heat fusing, ultrasonic welding, multifilament winds and or gluing to insure a good bond and seal. Thedistal end 142 ofballoon member 130 is completed sealed using any of the aforementioned techniques and positioned everted withincatheter lumen 128 proximal toproximal end 140. -
FIG. 3A shows an enlarged partial cross sectional view of the distal portion ofthrombectomy system 10 includingcatheter 20 havingdistal end 22.Balloon member 30 is shown in an inflated configuration longitudinally extending distal to catheterdistal end 22. In this configuration, balloon memberdistal end 42 is positioned distal to balloon memberproximal end 40. Extendingportion 44 ofballoon member 30 has a diameter slightly smaller thancatheter 20 and ranges from about 0.4 to about 0.99 times the diameter ofcatheter 20 and has a preferred range from about 0.5 to 0.9 times the diameter ofcatheter 20. Typically, the expanded diameter ofretrieval portion 50 is slightly larger than the inner diameter of the vessel at a target site to insure that the retrieval portion stays in contact with the vessel wall during the thrombus removal process.Balloon member 30 is typically formed of a thin walled polymeric tube having a proximal non-compliant portion defining extendingportion 44 coupled to a distal compliant portion definingretrieval portion 50 that has been sealed. The tube portions may be joined using known joining techniques such as, thermal fusing, ultrasonic welding, gluing, and solvent bonding. Suitable materials for the extending portion ofballoon member 30 include high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable. Suitable materials for theretrieval portion 50 ofballoon member 30 includes compliant polymeric elastomers such as silicones, urethanes, polyether block amide (PEBAX) and synthetic rubbers including polyisoprene, nitrile, chloroprene and ethylene propylene diene rubber. -
FIGS. 3B and 3C are partial cross sectional views of thrombectomy systems according to alternate embodiments of the present invention that illustrate different configurations of inflated extended balloon members.FIG. 3B shows an enlarged partial cross sectional view of the distal portion ofthrombectomy system 210 includingcatheter 220 havingdistal end 222.Balloon member 230 is shown in an inflated configuration longitudinally extending distal to catheterdistal end 222. In this configuration, balloon memberdistal end 242 is positioned distal to balloon memberproximal end 240. Extendingportion 244 ofballoon member 230 has a diameter slightly smaller thancatheter 220 and ranges from about 0.4 to about 0.99 times the diameter ofcatheter 220 and has a preferred range from about 0.5 to 0.9 times the diameter ofcatheter 220. Typically, the expanded diameter ofretrieval portion 250 is slightly larger than the inner diameter of the vessel at a target site to insure that the retrieval portion stays in contact with the vessel wall during the thrombus removal process.Balloon member 230 is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed.Balloon member 230 is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable. -
FIG. 3C shows an enlarged partial cross sectional view of the distal portion ofthrombectomy system 310.Balloon member 330 is shown in an inflated configuration longitudinally extending distal to catheterdistal end 322. In this configuration, balloon memberdistal end 342 and retrieval portion are positioned distal to balloon memberproximal end 340 and extendingportion 344. Extendingportion 344 ofballoon member 330 has a diameter slightly larger thancatheter 320 and ranges from about 1.0 to about 1.5 times the diameter ofcatheter 320 and has a preferred range from about 1.05 to 1.3 times the diameter ofcatheter 320. Typically, the expanded diameter ofretrieval portion 350 is slightly larger than the inner diameter of the vessel at a target site to insure that the retrieval portion stays in contact with the vessel wall during the thrombus removal process.Balloon member 330 is typically formed of a thin walled polymeric tube in which the distal end of the tube has been enlarged and sealed.Balloon member 330 is preferably formed of a high strength non-compliant polymeric material such as nylon, polyester and others, however, metallic materials such as thin-film nitinol or other alloys may also be suitable. -
FIGS. 4A through 4F illustrate a method of deploying a retrieval assembly at a target site within a body lumen according to one embodiment of the present invention. Thethrombectomy system 10 is positioned within avessel 400. Catheterdistal end 22 includingextendable balloon member 30 are positioned at a target site adjacent tothrombus 410. An inflation source member (not shown) is coupled to the proximal end of thecatheter 20 and used to apply fluid pressure to the lumen of catheter. The inflation source member preferably takes the form of a syringe (threaded or non-threaded), however other inflation sources such as a pressurized fluid source having a valve assembly or a controllable fluid delivery pump are also suitable. The preferred fluids include liquids such as saline and radiopaque contrasts solutions however gases such as carbon dioxide gas may be suitable for some system configurations. As the applied fluid pressure increases to a sufficient level,balloon member 30 begins to extend longitudinally from the catheter lumen. Asballoon member 30 extends longitudinally fromcatheter 20, leadingedge 415 of theballoon member 30 may encounterthrombus 410. While shown as large particle,thrombus 410 may have a varied composition that could comprise organized clot, tissue, plaque soft clot or even foreign objects. Dependant somewhat upon the size and composition ofthrombus 410balloon member 30 may extend longitudinally through a soft and compliant thrombus or between the inner vessel wall and a more rigid thrombus. Leadingedge 415 ofballoon member 30 is well suited to extend longitudinally between the more rigid thrombus and the vessel wall without perforating the vessel. With continued application of fluid pressure,balloon member 30 continues to extend longitudinally untilretrieval 50 is deployed and positioned distal tothrombus 410. Onceretrieval portion 50 is appropriately deployed, application of additional fluid pressure is unnecessary. As shown inFIG. 4E ,thrombectomy system 10 includingtether member 32 is pulled proximally causingretrieval portion 50 to engage the distal side ofthrombus 410.Tether member 32 ensures that sufficient retraction force is applied directly toretrieval portion 50 to movethrombus 410.Thrombectomy system 10 withthrombus 410 may then be removed from the body. Alternatively,thrombectomy system 10 with capturedthrombus 410 may be pulled proximally withinlarger catheter 420 havingdistal end 422 andlumen 424. Suction may then be applied tolumen 424 thus aiding retention ofthrombus 410 during removal or to fragment and removethrombus 410. - Novel devices, systems and methods have been disclosed to re-establish flow in a lumen of mammal. Although preferred embodiments of the invention have been described, it should be understood that various modifications including the substitution of elements or components which perform substantially the same function in the same way to achieve substantially the same result may be made by those skilled in the art without departing from the scope of the claims which follow.
Claims (8)
1. A thrombus removal system for use within the vasculature of a mammal comprising:
an elongate tubular flexible member having proximal and distal ends and a lumen extending therethrough;
a balloon member having proximal and distal ends, a longitudinally extending portion and a radially expanding retrieval portion where said proximal end of said balloon member is secured to the distal end of said flexible member,
an elongate flexible tether member slidably positioned within the lumen of said flexible member and having proximal and distal ends wherein the distal end of said tether member is coupled to the distal end of said balloon member,
said balloon member being operable by fluid pressure between a first configuration where said balloon member is collapsed and the distal end of said balloon member is everted and positioned within the lumen of said flexible member proximal to the proximal end of said balloon member and a second configuration where said balloon member is inflated and the distal end of said balloon member extends distal to the distal end of said flexible member.
2. The thrombus removal system of claim 1 wherein said retrieval portion is positioned distal to said extending portion.
3. The thrombus removal system of claim 1 wherein said balloon member includes a non-compliant material.
4. The thrombus removal system of claim 1 wherein said balloon member includes a compliant material.
5. The thrombus removal system of claim 1 wherein said balloon member comprises a metallic thin film.
6. The thrombus removal system of claim 1 wherein the diameter of said extending portion is smaller than the diameter of said flexible member.
7. The thrombus removal system of claim 1 wherein the diameter of said extending portion is larger than the diameter of said flexible member.
8. The thrombus removal system of claim 1 wherein the diameter of said retrieval portion is larger than the diameter of said extending portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/336,898 US20140336691A1 (en) | 2011-08-19 | 2014-07-21 | Methods and systems for performing thrombectomy procedures |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161525362P | 2011-08-19 | 2011-08-19 | |
US13/589,133 US8784442B2 (en) | 2011-08-19 | 2012-08-18 | Methods and systems for performing thrombectomy procedures |
US14/336,898 US20140336691A1 (en) | 2011-08-19 | 2014-07-21 | Methods and systems for performing thrombectomy procedures |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/589,133 Continuation US8784442B2 (en) | 2011-08-19 | 2012-08-18 | Methods and systems for performing thrombectomy procedures |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140336691A1 true US20140336691A1 (en) | 2014-11-13 |
Family
ID=47713179
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/589,133 Expired - Fee Related US8784442B2 (en) | 2011-08-19 | 2012-08-18 | Methods and systems for performing thrombectomy procedures |
US14/336,898 Abandoned US20140336691A1 (en) | 2011-08-19 | 2014-07-21 | Methods and systems for performing thrombectomy procedures |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/589,133 Expired - Fee Related US8784442B2 (en) | 2011-08-19 | 2012-08-18 | Methods and systems for performing thrombectomy procedures |
Country Status (1)
Country | Link |
---|---|
US (2) | US8784442B2 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9463035B1 (en) * | 2015-09-28 | 2016-10-11 | GW Medical LLC | Mechanical thrombectomy apparatuses and methods |
US10512478B2 (en) | 2016-04-25 | 2019-12-24 | Stryker Corporation | Clot-engulfing mechanical thrombectomy apparatuses |
US10517624B2 (en) | 2016-06-03 | 2019-12-31 | Stryker Corporation | Inverting thrombectomy apparatuses and methods |
US10610245B2 (en) | 2016-09-12 | 2020-04-07 | Stryker Corporation | Self-rolling thrombectomy apparatuses and methods |
US10743907B2 (en) | 2014-11-07 | 2020-08-18 | National University Of Ireland, Galway | Thrombectomy device |
US10779852B2 (en) | 2013-03-15 | 2020-09-22 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US10779843B2 (en) | 2017-11-09 | 2020-09-22 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US10835269B1 (en) | 2018-09-10 | 2020-11-17 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US10842513B2 (en) | 2016-04-25 | 2020-11-24 | Stryker Corporation | Methods for advancing inverting mechanical thrombectomy apparatuses in the vasculature |
US10888343B2 (en) | 2016-04-25 | 2021-01-12 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses and methods |
US11103265B2 (en) | 2018-05-14 | 2021-08-31 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US11253291B2 (en) | 2018-09-10 | 2022-02-22 | Stryker Corporation | Laser slotted grabbing device |
US11497512B2 (en) | 2016-04-25 | 2022-11-15 | Stryker Corporation | Inverting thrombectomy apparatuses and methods |
US11529158B2 (en) | 2004-03-25 | 2022-12-20 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11554005B2 (en) | 2018-08-13 | 2023-01-17 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11648028B2 (en) | 2012-11-20 | 2023-05-16 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US11697011B2 (en) | 2017-09-06 | 2023-07-11 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US11806033B2 (en) | 2017-01-10 | 2023-11-07 | Inari Medical, Inc. | Devices and methods for treating vascular occlusion |
US11849963B2 (en) | 2018-01-26 | 2023-12-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
US11864779B2 (en) | 2019-10-16 | 2024-01-09 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11896247B2 (en) | 2016-04-25 | 2024-02-13 | Stryker Corporation | Inverting mechanical thrombectomy apparatuses |
US11918243B2 (en) | 2015-10-23 | 2024-03-05 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US11937838B2 (en) | 2013-10-21 | 2024-03-26 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US11969331B2 (en) | 2022-10-28 | 2024-04-30 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2670313B1 (en) | 2011-02-01 | 2016-01-20 | St. Jude Medical, Inc. | Apparatus for heart valve repair |
GB201119794D0 (en) | 2011-11-16 | 2011-12-28 | Airway Medix Spolka Z O O | Ballooned ventilation tube cleaning device |
US10322253B2 (en) | 2011-03-29 | 2019-06-18 | Teleflex Life Sciences Unlimited Company | Ballooned ventilation tube cleaning device |
US9883855B2 (en) | 2012-01-25 | 2018-02-06 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
US9610082B2 (en) | 2012-01-25 | 2017-04-04 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
US10058348B2 (en) | 2012-02-02 | 2018-08-28 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
US9878132B2 (en) * | 2012-06-15 | 2018-01-30 | W. L. Gore & Associates, Inc. | Vascular occlusion and drug delivery devices, systems, and methods |
US10105219B2 (en) | 2012-08-02 | 2018-10-23 | St. Jude Medical, Cardiology Division, Inc. | Mitral valve leaflet clip |
US9662205B2 (en) | 2012-08-02 | 2017-05-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
US9125653B2 (en) * | 2012-08-02 | 2015-09-08 | St. Jude Medical, Cardiology Division, Inc. | Flexible nosecone for percutaneous device |
US9254141B2 (en) | 2012-08-02 | 2016-02-09 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
US9066710B2 (en) | 2012-10-19 | 2015-06-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
EP2754461B1 (en) * | 2013-01-14 | 2017-12-13 | Teleflex Medical Incorporated | Suction catheter device |
US9351779B2 (en) * | 2013-01-25 | 2016-05-31 | Kyphon SÀRL | Expandable device and methods of use |
US9642706B2 (en) | 2013-03-11 | 2017-05-09 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
US10070853B2 (en) * | 2013-08-14 | 2018-09-11 | Covidien Lp | Expandable balloon desufflation assembly |
US10500360B1 (en) | 2014-08-29 | 2019-12-10 | Teleflex Life Sciences Unlimited Company | Catheter for cleaning of tracheal ventilation tubes |
US9566144B2 (en) * | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
WO2017019572A1 (en) | 2015-07-24 | 2017-02-02 | Ichor Vascular Inc. | Embolectomy system and methods of making same |
GB2546082B (en) | 2016-01-06 | 2018-05-16 | Airway Medix S A | Closed suction system |
US11452831B2 (en) | 2016-01-06 | 2022-09-27 | Airway Medix S.A. | Closed suction system |
GB2548086B (en) * | 2016-03-01 | 2020-01-29 | Strait Access Tech Holdings Pty Ltd | An inflatable insertion device for percutaneous insertion |
US10946153B2 (en) | 2016-05-16 | 2021-03-16 | Teleflex Life Sciences Pte. Ltd. | Mechanical user control elements for fluid input module |
US20220104839A1 (en) | 2017-10-16 | 2022-04-07 | Retriever Medical, Inc. | Clot Removal Methods and Devices with Multiple Independently Controllable Elements |
WO2022082213A1 (en) | 2017-10-16 | 2022-04-21 | Retriever Medical, Inc. | Clot removal methods and devices with multiple independently controllable elements |
US10258357B1 (en) | 2017-10-16 | 2019-04-16 | Michael Bruce Horowitz | Catheter based retrieval device with proximal body having axial freedom of movement |
US11369400B2 (en) | 2019-03-20 | 2022-06-28 | Covidien Lp | Balloon dissector |
CN114224431A (en) * | 2021-11-25 | 2022-03-25 | 北京弘海微创科技有限公司 | Safe thrombus taking device |
CN115445059A (en) * | 2022-10-14 | 2022-12-09 | 恒壹(北京)医疗科技有限公司 | Automatic guiding balloon catheter and using method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4318410A (en) * | 1980-08-07 | 1982-03-09 | Thomas J. Fogarty | Double lumen dilatation catheter |
US5364345A (en) * | 1991-10-18 | 1994-11-15 | Imagyn Medical, Inc. | Method of tubal recanalization and catheter system therefor |
US5711754A (en) * | 1991-06-27 | 1998-01-27 | Nippon Zeon Co., Ltd. | Intra-aortic balloon catheter |
US6039721A (en) * | 1996-07-24 | 2000-03-21 | Cordis Corporation | Method and catheter system for delivering medication with an everting balloon catheter |
US20040181252A1 (en) * | 1999-11-19 | 2004-09-16 | Boyle Christopher T. | Balloon catheter having metal balloon and method of making same |
US7198632B2 (en) * | 2004-03-02 | 2007-04-03 | Boston Scientific Scimed, Inc. | Occlusion balloon catheter with longitudinally expandable balloon |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
DE8714529U1 (en) | 1987-10-31 | 1988-12-08 | Schnepp-Pesch, Wolfram, 7505 Ettlingen, De | |
US5108406A (en) | 1990-12-14 | 1992-04-28 | L.P. Wagi | Instrument to retrieve intraluminal objects |
US5217484A (en) | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5645075A (en) | 1992-02-18 | 1997-07-08 | Symbiosis Corporation | Jaw assembly for an endoscopic instrument |
US5222973A (en) | 1992-03-09 | 1993-06-29 | Sharpe Endosurgical Corporation | Endoscopic grasping tool surgical instrument |
US5304183A (en) | 1992-03-23 | 1994-04-19 | Laparomed Corporation | Tethered clamp retractor |
JP2552820B2 (en) | 1992-09-23 | 1996-11-13 | ターゲット セラピューティクス,インコーポレイテッド | Medical recovery equipment |
US5417703A (en) | 1993-07-13 | 1995-05-23 | Scimed Life Systems, Inc. | Thrombectomy devices and methods of using same |
US5782747A (en) | 1996-04-22 | 1998-07-21 | Zimmon Science Corporation | Spring based multi-purpose medical instrument |
US5868754A (en) | 1996-06-12 | 1999-02-09 | Target Therapeutics, Inc. | Medical retrieval device |
US5910144A (en) | 1998-01-09 | 1999-06-08 | Endovascular Technologies, Inc. | Prosthesis gripping system and method |
US6663650B2 (en) | 2000-06-29 | 2003-12-16 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
US6673100B2 (en) | 2001-05-25 | 2004-01-06 | Cordis Neurovascular, Inc. | Method and device for retrieving embolic coils |
US6989020B2 (en) | 2001-11-15 | 2006-01-24 | Cordis Neurovascular, Inc. | Embolic coil retrieval system |
US7549974B2 (en) * | 2002-06-01 | 2009-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for medical interventions of body lumens |
US7473266B2 (en) | 2003-03-14 | 2009-01-06 | Nmt Medical, Inc. | Collet-based delivery system |
US20080269774A1 (en) | 2006-10-26 | 2008-10-30 | Chestnut Medical Technologies, Inc. | Intracorporeal Grasping Device |
US8939991B2 (en) | 2008-06-08 | 2015-01-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
-
2012
- 2012-08-18 US US13/589,133 patent/US8784442B2/en not_active Expired - Fee Related
-
2014
- 2014-07-21 US US14/336,898 patent/US20140336691A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4318410A (en) * | 1980-08-07 | 1982-03-09 | Thomas J. Fogarty | Double lumen dilatation catheter |
US5711754A (en) * | 1991-06-27 | 1998-01-27 | Nippon Zeon Co., Ltd. | Intra-aortic balloon catheter |
US5364345A (en) * | 1991-10-18 | 1994-11-15 | Imagyn Medical, Inc. | Method of tubal recanalization and catheter system therefor |
US6039721A (en) * | 1996-07-24 | 2000-03-21 | Cordis Corporation | Method and catheter system for delivering medication with an everting balloon catheter |
US20040181252A1 (en) * | 1999-11-19 | 2004-09-16 | Boyle Christopher T. | Balloon catheter having metal balloon and method of making same |
US7198632B2 (en) * | 2004-03-02 | 2007-04-03 | Boston Scientific Scimed, Inc. | Occlusion balloon catheter with longitudinally expandable balloon |
Cited By (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11925369B2 (en) | 2004-03-25 | 2024-03-12 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11832837B2 (en) | 2004-03-25 | 2023-12-05 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11529158B2 (en) | 2004-03-25 | 2022-12-20 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11832838B2 (en) | 2004-03-25 | 2023-12-05 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11839393B2 (en) | 2004-03-25 | 2023-12-12 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11648028B2 (en) | 2012-11-20 | 2023-05-16 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US10874421B2 (en) | 2013-03-15 | 2020-12-29 | National University Of Ireland, Galway | Extraction devices |
US11406418B2 (en) | 2013-03-15 | 2022-08-09 | Vetex Medial Limited | Thrombectomy devices with control assemblies |
US10779852B2 (en) | 2013-03-15 | 2020-09-22 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US11317939B2 (en) | 2013-03-15 | 2022-05-03 | Vetex Medical Limited | Thrombectomy devices with maceration |
US10813663B2 (en) | 2013-03-15 | 2020-10-27 | National University Of Ireland, Galway | Device suitable for removing matter from inside the lumen and the wall of a body lumen |
US11278307B2 (en) | 2013-03-15 | 2022-03-22 | Vetex Medical Limited | Thrombectomy devices with aspiration |
US11896257B2 (en) | 2013-03-15 | 2024-02-13 | Vetex Medical Limited | Thrombectomy devices with control assemblies |
US11937838B2 (en) | 2013-10-21 | 2024-03-26 | Inari Medical, Inc. | Methods and apparatus for treating embolism |
US11963694B2 (en) | 2014-11-07 | 2024-04-23 | Vetex Medical Limited | Thrombectomy device |
US10743907B2 (en) | 2014-11-07 | 2020-08-18 | National University Of Ireland, Galway | Thrombectomy device |
US20170086864A1 (en) * | 2015-09-28 | 2017-03-30 | E. Skott Greenhalgh | Mechanical thrombectomy apparatuses and methods |
US9463035B1 (en) * | 2015-09-28 | 2016-10-11 | GW Medical LLC | Mechanical thrombectomy apparatuses and methods |
US10271864B2 (en) * | 2015-09-28 | 2019-04-30 | Stryker Corporation | Mechanical thrombectomy apparatuses and methods |
US11471176B2 (en) | 2015-09-28 | 2022-10-18 | Stryker Corporation | Biopsy methods |
US11026709B2 (en) | 2015-09-28 | 2021-06-08 | Stryker Corporation | Mechanical thrombectomy apparatuses and methods |
US11918243B2 (en) | 2015-10-23 | 2024-03-05 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US11918244B2 (en) | 2015-10-23 | 2024-03-05 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US10888342B2 (en) | 2016-04-25 | 2021-01-12 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses and methods |
US10561431B2 (en) | 2016-04-25 | 2020-02-18 | Stryker Corporation | Pre-loaded inverting tractor thrombectomy apparatuses and methods |
US10842513B2 (en) | 2016-04-25 | 2020-11-24 | Stryker Corporation | Methods for advancing inverting mechanical thrombectomy apparatuses in the vasculature |
US11497514B2 (en) | 2016-04-25 | 2022-11-15 | Stryker Corporation | Pre-loaded inverting tractor thrombectomy apparatuses and methods |
US11497512B2 (en) | 2016-04-25 | 2022-11-15 | Stryker Corporation | Inverting thrombectomy apparatuses and methods |
US10512478B2 (en) | 2016-04-25 | 2019-12-24 | Stryker Corporation | Clot-engulfing mechanical thrombectomy apparatuses |
US10888343B2 (en) | 2016-04-25 | 2021-01-12 | Stryker Corporation | Anti-jamming and macerating thrombectomy apparatuses and methods |
US11896247B2 (en) | 2016-04-25 | 2024-02-13 | Stryker Corporation | Inverting mechanical thrombectomy apparatuses |
US10517624B2 (en) | 2016-06-03 | 2019-12-31 | Stryker Corporation | Inverting thrombectomy apparatuses and methods |
US11559320B2 (en) | 2016-06-03 | 2023-01-24 | Stryker Corporation | Inverting thrombectomy apparatuses and methods |
US11627973B2 (en) | 2016-09-12 | 2023-04-18 | Stryker Corporation | Self-rolling apparatuses and methods for removing material from a body lumen |
US10610245B2 (en) | 2016-09-12 | 2020-04-07 | Stryker Corporation | Self-rolling thrombectomy apparatuses and methods |
US11806033B2 (en) | 2017-01-10 | 2023-11-07 | Inari Medical, Inc. | Devices and methods for treating vascular occlusion |
US11697012B2 (en) | 2017-09-06 | 2023-07-11 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US11865291B2 (en) | 2017-09-06 | 2024-01-09 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US11697011B2 (en) | 2017-09-06 | 2023-07-11 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US11844921B2 (en) | 2017-09-06 | 2023-12-19 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US10863999B2 (en) | 2017-11-09 | 2020-12-15 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US10835268B2 (en) | 2017-11-09 | 2020-11-17 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US11812980B2 (en) | 2017-11-09 | 2023-11-14 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US10856894B2 (en) | 2017-11-09 | 2020-12-08 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US10912576B2 (en) | 2017-11-09 | 2021-02-09 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US10779843B2 (en) | 2017-11-09 | 2020-09-22 | Stryker Corporation | Inverting thrombectomy apparatuses having enhanced tracking |
US11849963B2 (en) | 2018-01-26 | 2023-12-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
US11896251B2 (en) | 2018-05-14 | 2024-02-13 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US11103265B2 (en) | 2018-05-14 | 2021-08-31 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US11963861B2 (en) | 2018-08-13 | 2024-04-23 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11890180B2 (en) | 2018-08-13 | 2024-02-06 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11833023B2 (en) | 2018-08-13 | 2023-12-05 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11554005B2 (en) | 2018-08-13 | 2023-01-17 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11744691B2 (en) | 2018-08-13 | 2023-09-05 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11559382B2 (en) | 2018-08-13 | 2023-01-24 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11642209B2 (en) | 2018-08-13 | 2023-05-09 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US10835269B1 (en) | 2018-09-10 | 2020-11-17 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US11253291B2 (en) | 2018-09-10 | 2022-02-22 | Stryker Corporation | Laser slotted grabbing device |
US11771450B2 (en) | 2018-09-10 | 2023-10-03 | Stryker Corporation | Inverting thrombectomy apparatuses and methods of use |
US11937834B2 (en) | 2019-10-16 | 2024-03-26 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11864779B2 (en) | 2019-10-16 | 2024-01-09 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11969178B2 (en) | 2021-09-16 | 2024-04-30 | Inari Medical, Inc. | Method for treating vascular occlusion |
US11969331B2 (en) | 2022-10-28 | 2024-04-30 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11969332B2 (en) | 2023-04-04 | 2024-04-30 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US11969333B2 (en) | 2023-06-05 | 2024-04-30 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
Also Published As
Publication number | Publication date |
---|---|
US20130046332A1 (en) | 2013-02-21 |
US8784442B2 (en) | 2014-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8784442B2 (en) | Methods and systems for performing thrombectomy procedures | |
US11786254B2 (en) | Methods of managing neurovascular obstructions | |
US9320532B2 (en) | Expandable tip assembly for thrombus management | |
US8197493B2 (en) | Method for providing progressive therapy for thrombus management | |
US20120330342A1 (en) | Systems and devices for intralumenal implantation | |
US20120330350A1 (en) | Methods and systems for performing thrombectomy procedures | |
US8778007B2 (en) | Systems for performing intralumenal reconstruction | |
US20150238195A1 (en) | Methods and systems for performing intralumenal procedures | |
US11730500B2 (en) | Catheter with distal interventional element | |
US20130046326A1 (en) | Methods and systems for performing intralumenal procedures | |
AU2014201810B2 (en) | Blood flow restoration and thrombus management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |